Scott Guenthner

Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis

Mark Lebwohl, Linda Stein Gold, Bruce Strober et al. · New England Journal of Medicine · 2021 · 178 citations

Medicine, Dermatology, Pharmacotherapy +16

A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial

Andrew Blauvelt, Kim Papp, Alice B. Gottlieb et al. · British Journal of Dermatology · 2019 · 172 citations · Full text

Pharmacy, Dermatology, Pharmacotherapy +15

Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis

Eric L. Simpson, Melinda Gooderham, Andreas Wollenberg et al. · JAMA Dermatology · 2023 · 143 citations · Full text

Medicine, Dermatology, Pharmacotherapy +17

Cutaneous squamous cell carcinomas consistently show histologic evidence of in situ changes: A clinicopathologic correlation

Scott Guenthner, Robert Hurwitz, Larry J. Buckel et al. · Journal of the American Academy of Dermatology · 1999 · 87 citations

Medicine, Dermatology, Pathology +16

Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind Clinical Trials.

Angela Moore, Lawrence J. Green, Suzanne Bruce et al. · PubMed · 2018 · 65 citations

Medicine, Pharmacology, Pharmacotherapy +15